Endocrinology 143(11):43974408 Green BD, Mooney MH, Gault VA, Irwin N, Bailey CJ, Harriott P, Greer B, OHarte FP, Flatt PR (2004 Mar) N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity
doi: 10.3390/biom11020185 21 HuthTEaton-FitchNStainesDMarshall-GradisnikS
For an intramuscular (IM) injection, the usual choice is a 22 to 25 gauge needle, 1 to 1.5 inches long
Available sizes include 10 mg, 20 mg, subject to live stock
By mimicking these hormones, the drug does the following: Increases insulin secretion, resulting in lower blood sugar Decreases glucagon production (For those with diabetes, unchecked glucagon production can result in blood sugars that are too high.) Slows gastric emptying (process by which the contents of the stomach are emptied into the duodenum, the first part of the small intestine)